Effect of Yoga on Non-alcoholic fatty Liver
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2020/11/029262
- Lead Sponsor
- Rakhi Mishra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Age between 25 to 50 years.
Liver steatosis grade II & III diagnosed with Fibroscan (Fibrosis score F2 and F3; 7.5 to 10 kPa and 10-14 kPa respectively and Steatosis grade higher than 290 dB/m) [Memorial Sloan Kettering cancer center]
BMI
Overweight - 25-29.9
Obese - >= 30
Obese Type-I - 30-40
Obese Type-II - 40.1- 50
Obese Type III - >50
Medically Diagnosed with Hypertension
Enrolled under any other lifestyle modification program like gym, meditation
Diagnosed with neurological, cardiovascular or orthopedic issues.
Diagnosed with liver disease of other etiology.
Practicing Regular Yoga
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anthropometric measurement: <br/ ><br>BMI, Waist circumference, Waist/Hip Ratio <br/ ><br>Surrogate Biomarkers: <br/ ><br>AST, ALT, GGT <br/ ><br>Lipid profile <br/ ><br>Triglycerides HDL-cholesterol <br/ ><br>Leptin <br/ ><br>C-reactive Protein <br/ ><br>Fasting glucose <br/ ><br>Albumin <br/ ><br>Platelets <br/ ><br>Steatosis Grade:Fibrosis score <br/ ><br>CAP score <br/ ><br>Timepoint: Pre-Interventional <br/ ><br>Baseline assessment <br/ ><br>Day 1 <br/ ><br>Post Interventional assessment- <br/ ><br>First- 12th week <br/ ><br>Second-24th week <br/ ><br>
- Secondary Outcome Measures
Name Time Method To develop standardized protocol for non-alcoholic fatty liver disease <br/ ><br>Timepoint: 24th week